Found: 17
Select item for more details and to access through your institution.
Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2417377, doi. 10.1001/jamanetworkopen.2024.17377
- By:
- Publication type:
- Article
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.
- Published in:
- Trials, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s13063-023-07834-8
- By:
- Publication type:
- Article
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.
- Published in:
- Trials, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s13063-023-07834-8
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1427, doi. 10.1007/s40262-023-01288-6
- By:
- Publication type:
- Article
Ordinary people, criminals, addicts and recreational users: Swedish court of law descriptions of persons sentenced for online drug purchases.
- Published in:
- Nordic Studies on Alcohol & Drugs / Nordisk Alkohol- & Narkotikatidskrift, 2022, v. 39, n. 3, p. 225, doi. 10.1177/14550725221079524
- By:
- Publication type:
- Article
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 5, p. e219041, doi. 10.1001/jamanetworkopen.2021.9041
- By:
- Publication type:
- Article
Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder.
- Published in:
- Addiction, 2019, v. 114, n. 8, p. 1416, doi. 10.1111/add.14636
- By:
- Publication type:
- Article
Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade: An Open-Label Phase 1 Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 3, p. 460, doi. 10.1111/bcp.12698
- By:
- Publication type:
- Article
Treatment of oral mucositis pain following radiation therapy for head-and-neck cancer using a bioadhesive barrier-forming lipid solution.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 6, p. 1557, doi. 10.1007/s00520-014-2117-3
- By:
- Publication type:
- Article
The use of MuGard™, Caphosol®, and episil® in patients undergoing chemoradiotherapy for squamous cell carcinoma of the head and neck.
- Published in:
- Journal of Radiotherapy in Practice, 2014, v. 13, n. 1, p. 123, doi. 10.1017/S1460396913000472
- By:
- Publication type:
- Article
The use of MuGard™, Caphosol®, and episil® in patients undergoing chemoradiotherapy for squamous cell carcinoma of the head and neck.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Boundary lubrication under water.
- Published in:
- Nature, 2006, v. 444, n. 7116, p. 191, doi. 10.1038/nature05196
- By:
- Publication type:
- Article